Document Submission
19/03/2021Circular/Notice to Shareholders
| SUNZEN BIOTECH BERHAD |
| Subject | CIRCULAR TO SHAREHOLDERS IN RELATION TO THE:- (I) PROPOSED ACQUISITION BY SUNZEN BIOTECH BERHAD ("SUNZEN") OF 2,000,000 ORDINARY SHARES IN FINSOURCE SOLUTION SDN BHD (FORMERLY KNOWN AS SAVE SOLUTION SDN BHD) ("FSSB"), REPRESENTING 100% OF THE EQUITY INTEREST IN FSSB FROM TEO YEK MING, CHING CHEE PUN, LEE CHING YONG AND LOW CHEE YEAP, FOR A PURCHASE CONSIDERATION OF RM6,800,000 TO BE WHOLLY SATISFIED BY THE ISSUANCE AND ALLOTMENT OF 41,212,121 NEW ORDINARY SHARES IN SUNZEN ("SUNZEN SHARES") AT AN ISSUE PRICE OF RMO.165 PER SUNZEN SHARE ("PROPOSED ACQUISITION"); AND; (II) PROPOSED DIVERSIFICATION INTO MONEY LENDING |
Please refer attachment below.
Attachments |
Announcement Info
| Company Name | SUNZEN BIOTECH BERHAD |
| Stock Name | SUNZEN |
| Date Announced | 19 Mar 2021 |
| Category | Document Submission |
| Reference Number | DCS-19032021-00006 |
Related Announcements for SUNZEN
| Date | Title |
|---|---|
| 28/04/2022 | Circular/Notice to Shareholders |
| 28/04/2022 | Annual Report & CG Report |
| 28/04/2022 | Circular/Notice to Shareholders |
| 28/05/2021 | Annual Report & CG Report |
| 28/05/2021 | Circular/Notice to Shareholders |
| 21/01/2021 | Circular/Notice to Shareholders |
| 03/11/2020 | Circular/Notice to Shareholders |
| 29/06/2020 | Annual Report & CG Report |
| 29/06/2020 | Circular/Notice to Shareholders |
| 30/05/2019 | Annual Report & CG Report |